ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2014

Cost-utility analysis of glucagon-like Peptide-1 agonists compared with dipeptidyl peptidase-4 inhibitors or neutral protamine hagedorn Basal insulin as add-on to metformin in type 2 diabetes in sweden.

Aliasghar A Kiadaliri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.